Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
about
Targeting chronic lymphocytic leukemia cells in the tumor microenviroment: A review of the in vitro and clinical trials to dateRuxolitinib for symptom control in patients with chronic lymphocytic leukaemia: a single-group, phase 2 trial.Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance.A combination of cytokines rescues highly purified leukemic CLL B-cells from spontaneous apoptosis in vitro.Circulating immune/inflammation markers in Chinese workers occupationally exposed to formaldehydeIdentification and characterization of distinct IL-17F expression patterns and signaling pathways in chronic lymphocytic leukemia and normal B lymphocytesAggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patientsLenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II StudyC-C motif ligand 11 reduction in CLL patients serum after vitamin D supplementationTargeting inflammatory pathways in chronic lymphocytic leukemia.CXCL9: evidence and contradictions for its role in tumor progression.Role of chemokines and their receptors in chronic lymphocytic leukemia: function in microenvironment and targeted therapy.B cell receptor signaling in chronic lymphocytic leukemia.The skewed balance between Tregs and Th17 in chronic lymphocytic leukemia.Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia.IL-10 production by CLL cells is enhanced in the anergic IGHV mutated subset and associates with reduced DNA methylation of the IL10 locus.Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).Increased risk of axial fractures in patients with untreated chronic lymphocytic leukemia: a population-based analysis.The correlations between IL-17 vs. Th17 cells and cancer patient survival: a systematic review.Nurse-like cells control the activity of chronic lymphocytic leukemia B cells via galectin-1.MCP-1, KC-like and IL-8 as critical mediators of pathogenesis caused by Babesia canis.Evaluation of Bronchoalveolar Lavage Fluid Cytokines as Biomarkers for Invasive Pulmonary Aspergillosis in At-Risk Patients.Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells.Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697).A Comprehensive Safety Trial of Chimeric Antibody 14.18 With GM-CSF, IL-2, and Isotretinoin in High-Risk Neuroblastoma Patients Following Myeloablative Therapy: Children's Oncology Group Study ANBL0931.Extracellular galectins as controllers of cytokines in hematological cancer
P2860
Q26798062-44A963E9-9ACE-4C6C-82F0-0498F6970EACQ33438420-FC94D62A-41A0-4B07-B9B4-988F877AD783Q33634642-B307E788-97EB-45FB-893C-3B4950FEE21DQ34653811-ED693F33-3283-4E1E-9C08-FDB42C9667D0Q35975357-F14357DC-2CFF-45A8-A22C-964C3977F607Q36289973-A85BB3A6-5EF4-4D4A-A6B1-184E8CC85E13Q36476656-20DC6F2B-FEB7-4879-9A55-327924187ECFQ36715966-55EAA8A6-B775-41AF-B8BF-1EDDD333D6BAQ36759124-42E9949E-E5EF-4B21-95A9-800EF0467134Q37125164-34B785DD-A0F8-4DA5-A298-86142CC7A60DQ37351312-18D892B1-49F6-4F4C-BD22-4AF5D8B359C9Q37429985-41CFA2F4-800E-4609-81FE-4A738A158F51Q37610087-C1DB895C-A377-4D39-BAC9-C8F8B11A826CQ38127513-96EAD9E7-1F93-4CC0-9348-093D038B7849Q38473746-AE86C632-7E5D-4B8B-98AC-7436FCD0BD33Q39026190-58B8B8DB-0F9B-43F8-8E39-27B084635D20Q39150343-67A80E38-3804-4D2E-960F-6ECDD716428AQ40475054-F6053AB2-30A3-4D3F-8B79-CF63AEDBE77FQ42335809-8A86E797-B818-42C3-A14F-A5FEF4B70F59Q42600273-181EA0D5-DDCC-4453-8A58-F1B632153F4EQ45026775-8BB71DD9-9DA2-4F15-AE1D-1686A4D643B6Q47229730-04C1C589-E4FB-4B76-B1B8-2F5D3E72E67DQ47314392-88261CDA-F062-4BFE-BDC0-1D804F091953Q48103978-BE1890C4-0E78-4A2E-8DE1-82FA6DFFBE0BQ53491955-B92FD511-6874-4EDE-AEE7-C47BCA391E60Q55501991-1DF38E47-EA2B-4918-81D1-096254404D83Q58803547-48A42665-7878-4188-A06E-CF9CA98A61EB
P2860
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@ast
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@en
type
label
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@ast
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@en
prefLabel
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@ast
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@en
P2093
P2860
P1433
P1476
Identification of outcome-correlated cytokine clusters in chronic lymphocytic leukemia
@en
P2093
Barbara Sherry
Cristina Sison
Igor Dozmorov
Jonathan E Kolitz
Kanti R Rai
Michael Centola
Nicholas Chiorazzi
Preetesh Jain
Sophia Yancopoulos
Steven L Allen
P2860
P304
P356
10.1182/BLOOD-2011-03-342436
P407
P577
2011-09-12T00:00:00Z